DK139691A - Fremgangsmaade til fremstilling af 3,7-disubstituerede 3-cephem-4-carboxylsyreforbindelser - Google Patents

Fremgangsmaade til fremstilling af 3,7-disubstituerede 3-cephem-4-carboxylsyreforbindelser Download PDF

Info

Publication number
DK139691A
DK139691A DK139691A DK139691A DK139691A DK 139691 A DK139691 A DK 139691A DK 139691 A DK139691 A DK 139691A DK 139691 A DK139691 A DK 139691A DK 139691 A DK139691 A DK 139691A
Authority
DK
Denmark
Prior art keywords
cephem
disubstituted
preparing
carboxylic acid
acid compounds
Prior art date
Application number
DK139691A
Other languages
English (en)
Other versions
DK139691D0 (da
Inventor
Takashi Kamiya
Kunihiko Tanaka
Yoshiharu Nakai
Kazuo Sakane
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9425/76A external-priority patent/GB1575803A/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of DK139691A publication Critical patent/DK139691A/da
Publication of DK139691D0 publication Critical patent/DK139691D0/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/40Unsubstituted amino or imino radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/46Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/48Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/50Nitrogen atoms bound to hetero atoms
    • C07D277/52Nitrogen atoms bound to hetero atoms to sulfur atoms, e.g. sulfonamides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK911396A 1976-03-09 1991-07-25 Fremgangsmaade til fremstilling af 3,7-disubstituerede 3-cephem-4-carboxylsyreforbindelser DK139691D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9425/76A GB1575803A (en) 1976-03-09 1976-03-09 3,7 disubstituted 3 cephem 4 carboxylic acid compounds andprocesses for the preparation thereof
GB4114576 1976-10-04

Publications (2)

Publication Number Publication Date
DK139691A true DK139691A (da) 1991-07-25
DK139691D0 DK139691D0 (da) 1991-07-25

Family

ID=26242927

Family Applications (2)

Application Number Title Priority Date Filing Date
DK101477A DK168863B1 (da) 1976-03-09 1977-03-08 Thiazolderivater til anvendelse som udgangsmateriale til fremstilling af 3-cephem-4-carboxylsyrederivater, som er substitueret i 7 stillingen
DK911396A DK139691D0 (da) 1976-03-09 1991-07-25 Fremgangsmaade til fremstilling af 3,7-disubstituerede 3-cephem-4-carboxylsyreforbindelser

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK101477A DK168863B1 (da) 1976-03-09 1977-03-08 Thiazolderivater til anvendelse som udgangsmateriale til fremstilling af 3-cephem-4-carboxylsyrederivater, som er substitueret i 7 stillingen

Country Status (10)

Country Link
US (1) US4560765A (da)
AR (2) AR218241A1 (da)
CA (1) CA1218054A (da)
DE (1) DE2760288A1 (da)
DK (2) DK168863B1 (da)
ES (5) ES456625A1 (da)
HU (2) HU179016B (da)
IE (1) IE44888B1 (da)
MX (1) MX4658E (da)
SE (2) SE437832B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE55406B1 (en) * 1982-08-07 1990-09-12 Tanabe Seiyaku Co Novel cephalosporin compounds and preparation thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4093803A (en) * 1971-05-14 1978-06-06 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(thienyl-, furyl- or pyridylacetamido)] cephalosporins
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
SE417968B (sv) * 1972-10-20 1981-04-27 Fujisawa Pharmaceutical Co Forfarande for framstellning av penamderivat
US4113940A (en) * 1973-03-15 1978-09-12 Fujisawa Pharmaceutical Co., Ltd. 7-amino 2-lower alkyl-2 or 3-cephem-4-carboxylic acid derivatives and processes for preparation thereof
JPS5119765A (en) * 1974-08-09 1976-02-17 Takeda Chemical Industries Ltd Aminochiazoorujudotaino seizoho
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
US4298606A (en) * 1974-12-19 1981-11-03 Takeda Chemical Industries, Ltd. Thiazolylacetamido compounds
GR63088B (en) * 1976-04-14 1979-08-09 Takeda Chemical Industries Ltd Preparation process of novel cephalosporins

Also Published As

Publication number Publication date
SE437832B (sv) 1985-03-18
ES476075A1 (es) 1979-05-16
AR218241A1 (es) 1980-05-30
ES476076A1 (es) 1979-05-16
ES467635A1 (es) 1979-09-01
IE44888B1 (en) 1982-05-05
AR222010A1 (es) 1981-04-15
CA1218054A (en) 1987-02-17
DK168863B1 (da) 1994-06-27
SE7702547L (sv) 1977-09-10
SE8302027L (sv) 1983-04-12
IE44888L (en) 1977-09-09
DK101477A (da) 1977-09-10
US4560765A (en) 1985-12-24
ES456625A1 (es) 1978-07-16
HU176455B (en) 1981-03-28
HU179016B (en) 1982-08-28
SE454988B (sv) 1988-06-13
ES476077A1 (es) 1979-05-16
DE2760288A1 (da) 1985-05-09
MX4658E (es) 1982-07-19
DK139691D0 (da) 1991-07-25
SE8302027D0 (sv) 1983-04-12

Similar Documents

Publication Publication Date Title
DK157026C (da) Fremgangsmaade til fremstilling af 7-oed-alfa-amino-alfa-(p-hydroxy-phenyl)acetamidoaa-3-methyl-cephem-4-carboxylsyre
DK162391C (da) Analogifremgangsmaade til fremstilling af syn-isomerer af 3,7-disubstituerede 3-cephem-4-carboxylsyreforbindelser
NL7701965A (nl) Werkwijze ter bereiding van bis-pyridiniumver- bindingen, alsmede werkwijze ter bereiding van bis-pyridiniumverbindingen bevattende preparaten.
NL7707467A (nl) Werkwijze ter bereiding van hexahydrodibenzo- pyranonverbindingen.
DK286777A (da) Fremgangsmade til fremstilling af penicillansyrederivater
ES451634A0 (es) Un metodo de preparar compuestos de alcoxisilano.
DK158669C (da) Fremgangsmaade til fremstilling af 6beta-halogensubstituerede penicillansyrederivater.
DK152368C (da) Fremgangsmaade til fremstilling af krystallinsk 7-oed-alfa-amino-alfa-(p-hydroxyphenyl)acetamidoaa-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylsyre-1,2-propylenglycolat
DK99980A (da) Fremgangsmaade til fremstilling af mercaptoacyldihydropyrazolcarboxylsyrederivater
DK455877A (da) Fremgangsmaade til fremstilling af phenyleddikesyrederivater
NL7700406A (nl) Werkwijze ter bereiding van nieuwe 7-aminothiazolyl- aceetamidocefalosporaanzuurverbinding.
DK144912C (da) Fremgangsmaade til fremstilling af substituerede 2,6-methano-3,4,5,6-tetrahydro-2h-1-benzoxociner
NO772959L (no) Fremgangsmaate til fremstilling av substituerte purinforbindelser
DK236677A (da) Fremgangsmade til fremstilling af kvadratsyre
NL7701270A (nl) Werkwijze ter bereiding van nieuwe 3-carbamoyl- oxymethyl 7-(amino-4-thiazolylaceetamido)cefa- losporaanzuurverbindingen.
NL7713916A (nl) Werkwijze ter bereiding van nieuwe sulfamoyl- benzoezuurderivaten.
DK144277C (da) Fremgangsmaade til fremstilling af 6-aminopenicillansyre
DK154085C (da) Fremgangsmaade til fremstilling af 1,1-dioxopenicillansyrederivater
DK143346C (da) Fremgangsmaade til fremstilling af 0,0-dialkylthionophosphorsyrechlorider
DK139691A (da) Fremgangsmaade til fremstilling af 3,7-disubstituerede 3-cephem-4-carboxylsyreforbindelser
DK149962C (da) Fremgangsmaade til fremstilling af 2,5-diketogluconsyre
DK152497C (da) Fremgangsmaade til fremstilling af 8-substituerede 2-amino-5-oxo-5,8-dihydropyridooe2,3-daapyrimidin-6-carboxylsyrer
DK148886C (da) Fremgangsmaade til fremstilling af diacetone-2-ketogulonsyre
DK145741C (da) Fremgangsmaade til fremstilling af 6-chlor-alfa-methyl-carbazol-2-eddikesyre
DK144823C (da) Fremgangsmaade til fremstilling af o,o-dialkyl-thiophosphorsyreesterchlorider

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment
PUP Patent expired